Human Genome Epidemiology Literature Finder
Records 1 - 12 (of 12 Records) |
Query Trace: Neutropenia and XRCC3[original query] |
---|
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy. The pharmacogenomics journal 2008 Aug 8 (4): 278-88. Ruzzo A, Graziano F, Loupakis F, Santini D, Catalano V, Bisonni R, Ficarelli R, Fontana A, Andreoni F, Falcone A, Canestrari E, Tonini G, Mari D, Lippe P, Pizzagalli F, Schiavon G, Alessandroni P, Giustini L, Maltese P, Testa E, Menichetti E T, Magnani |
A pharmacogenomic study of docetaxel and gemcitabine for the initial treatment of advanced non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007 Mar 2 (3): 197-202. Petty W Jeffrey, Knight Sommer N, Mosley Libyadda, Lovato James, Capellari James, Tucker Robert, Blackstock A William, Miller Mark Steven, Miller Antonius |
[Polymorphisms of RAD51(G135C) and XRCC3(C241T) genes and correlations thereof with prognosis and clinical outcomes of acute myeloid leukemia]. Zhonghua yi xue za zhi 2008 Feb 88 (6): 378-82. Liu Liang, Yang Lin, Zhang Yue, Xu Ze-Feng, Yu Ming-Hua, Wang Jian-Xiang, Xiao Zhi-Ji |
Cisplatin plus weekly CPT-11/docetaxel in advanced esophagogastric cancer: a phase I study with pharmacogenetic assessment of XPD, XRCC3 and UGT1A1 polymorphisms. Cancer chemotherapy and pharmacology 2008 Nov 62 (6): 1075-83. Font Albert, Salazar Ramon, Maurel Joan, Taron Miquel, Ramirez Jose Luis, Tabernero Josep, Gallego Rosa, Casado Esther, Manzano Jose Luis, Carcereny Enric, Guix Marta, Fernández-Llamazares Jaume, Rosell Rafa |
Nucleotide excision repair gene polymorphisms may predict acute toxicity in patients treated with chemoradiotherapy for bladder cancer. Pharmacogenomics 2010 Oct 11 (10): 1377-87. Sakano Shigeru, Hinoda Yuji, Sasaki Miwa, Wada Takashi, Matsumoto Hiroaki, Eguchi Satoshi, Shinohara Asano, Kawai Yoshihisa, Hara Tomohiko, Nagao Kazuhiro, Hara Takahiko, Naito Katsusuke, Matsuyama Hideya |
Chemotherapy-induced neutropenia does not correlate with DNA repair gene polymorphisms and treatment efficacy in advanced non-small-cell lung cancer patients. Clinical lung cancer 2011 Jul 12 (4): 224-30. Iranzo Vega, Sirera Rafael, Bremnes Roy M, Blasco Ana, Jantus-Lewintre Eloísa, Tarón Miquel, Berrocal Alfonso, Blasco Sara, Caballero Cristina, Del Pozo Nieves, Rosell Rafael, Camps Carl |
Carboplatin plus pemetrexed for platinum-pretreated, advanced non-small cell lung cancer: a retrospective study with pharmacogenetic evaluation. Cancer chemotherapy and pharmacology 2011 Dec 68 (6): 1405-12. Metro Giulio, Chiari R, Mare M, Giannarelli D, Tofanetti F R, Minotti V, Ferraldeschi M, Giuffrida D, Marcomigni L, Bennati C, Fischer M J, Meacci M, Bellavita R, Pistola L, Ludovini V, Crinò |
DNA repair polymorphisms and treatment outcomes of patients with malignant mesothelioma treated with gemcitabine-platinum combination chemotherapy. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012 Oct 7 (10): 1609-17. Er?ulj Nina, Kova? Viljem, Hmeljak Julija, Franko Alenka, Dodi?-Fikfak Metoda, Dolžan Vi |
A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen. The pharmacogenomics journal 2013 Oct 13 (5): 403-9. Cecchin E, D'Andrea M, Lonardi S, Zanusso C, Pella N, Errante D, De Mattia E, Polesel J, Innocenti F, Toffoli |
Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients. Scientific reports 2014 4 6828. Ruzzo Annamaria, Graziano Francesco, Galli Fabio, Giacomini Elisa, Floriani Irene, Galli Francesca, Rulli Eliana, Lonardi Sara, Ronzoni Monica, Massidda Bruno, Zagonel Vittorina, Pella Nicoletta, Mucciarini Claudia, Labianca Roberto, Ionta Maria Teresa, Veltri Enzo, Sozzi Pietro, Barni Sandro, Ricci Vincenzo, Foltran Luisa, Nicolini Mario, Biondi Edoardo, Bramati Annalisa, Turci Daniele, Lazzarelli Silvia, Verusio Claudio, Bergamo Francesca, Sobrero Alberto, Frontini Luciano, Magnani Mau |
Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy. Cancer chemotherapy and pharmacology 2015 Apr 75 (4): 763-72. Joerger M, Huitema A D R, Boot H, Cats A, Doodeman V D, Smits P H M, Vainchtein L, Rosing H, Meijerman I, Zueger M, Meulendijks D, Cerny T D, Beijnen J H, Schellens J H |
Relevance of pharmacogenetic polymorphisms with response to docetaxel, cisplatin, and 5-fluorouracil chemotherapy in esophageal cancer. Investigational new drugs 2021 11 40 (2): 420-429. Nomura Hisanaga, Tsuji Daiki, Ueno Shohei, Kojima Takashi, Fujii Satoshi, Yano Tomonori, Daiko Hiroyuki, Demachi Ken, Itoh Kunihiko, Kawasaki Toshikat |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: